ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Christopher · 1 0 0 0

Patient basic information Patient: Mr. Christopher (Christopher Morris) Nationality: Peru Diagnosis: Gynecological Oncology Diagnostic Hospital: University of Hong Kong Shenzhen Hospital Treatment: Insulin therapy + medication Holidays: 128 days Treatment cost: about 219,771 yuan Treatment effect: Quality of life improvement Due to limited local medical conditions, the patient's condition continued to deteriorate, and after consultation with multiple parties, the decision was made to travel to China to seek more professional treatment. The treatment process After patients arrived in China, the Shenzhen Hospital of the University of Hong Kong organized multidisciplinary consultations and developed detailed treatment plans.

After 128 days of careful treatment, the patient's condition is effectively controlled and quality of life improved. Patients and their families are very satisfied with the treatment effect, and the level of expertise and service of the Chinese medical team is highly appreciated. Patients commented, 'Thanks to the excellent and knowledgeable care of Chinese doctors!

During this period of Chinese medicine, we have been treated with the warmth of the general practitioner. We will recommend China's medical services to those who need more help. 'The case is a typical case of gynecological tumors, where patients from Peru choose to come to China after poor local treatment.

The multidisciplinary team at the University of Hong Kong Shenzhen Hospital successfully helped patients control the disease through a comprehensive system of in vitro + drug treatment. This case fully reflects the advanced level of Chinese medicine in the field of gynecological oncology and the expertise of international medical services.

秘鲁,妇科肿瘤,香港大学深圳医院,国际医疗,来华就医